Professor
University of Manchester
Manchester, United Kingdom
Professor of Rheumatology at The University of Manchester UK and Director of the NIHR Manchester Biomedical Research Centre. His major area of research expertise is in long-term outcomes in lupus as well as clinical trials and personalised medicine in SLE.
Monday, November 13, 2023
2:00 PM – 2:15 PM PT
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Aurinia: Consultant (Ongoing); Eli Lilly: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2020)
Treating Inflammation to Improve CVD Outcomes in Non-autoimmune Populations
Tuesday, November 14, 2023
12:30 PM – 12:45 PM PT
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Aurinia: Consultant (Ongoing); Eli Lilly: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2020)
